Cover Image
市場調查報告書

臨床決策支援系統的全球市場 - 至2023年的預測:整合型,獨立式

Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), Patient Care Setting - Global Forecasts to 2023

出版商 MarketsandMarkets 商品編碼 296626
出版日期 內容資訊 英文 201 Pages
訂單完成後即時交付
價格
Back to Top
臨床決策支援系統的全球市場 - 至2023年的預測:整合型,獨立式 Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), Patient Care Setting - Global Forecasts to 2023
出版日期: 2018年03月16日 內容資訊: 英文 201 Pages
簡介

臨床決策支援系統 (CDSS) 市場,預計從2018年的10億190萬美元,到2023年擴大到17億5200萬美元。預計市場2018年∼2023年以11.8%的年複合成長率成長。

本報告提供全球臨床決策支援系統市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 臨床決策支援系統市場概要
  • 臨床決策支援系統市場:各模式
  • 臨床決策支援系統市場:關聯性的各等級
  • 臨床決策支援系統市場:各用途
  • 臨床決策支援系統市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
    • 美國的法規形勢

第6章 案例研究

  • 簡介
  • HIV患者的早期發現
  • 削減敗血症的死亡率
  • 削減不必要的檢驗
  • 誤診的削減

第7章 臨床決策支援系統的全球市場:各零件

  • 簡介
  • 服務
  • 軟體
  • 硬體設備

第8章 臨床決策支援系統的全球市場:各產品

  • 簡介
  • 整合型
  • 獨立式

第9章 臨床決策支援系統的全球市場:各類型

  • 簡介
  • 治療
  • 診斷

第10章 臨床決策支援系統的全球市場:各模式

  • 簡介
  • 知識密集型
  • 非知識密集型

第11章 臨床決策支援系統的全球市場:各提供方法

  • 簡介
  • 內部部署
  • 雲端基礎

第12章 臨床決策支援系統的全球市場:各用途

  • 簡介
  • 傳統
  • 先進型

第13章 臨床決策支援系統的全球市場:關聯性的各等級

  • 簡介
  • 活性
  • 被動式

第14章 臨床決策支援系統的全球市場:各環境

  • 簡介
  • 住院治療環境
  • 門診病人治療環境

第15章 臨床決策支援系統的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第16章 競爭情形

  • 概要
  • 企業的排行榜和產業的集中
  • 競爭模式

第17章 企業簡介

  • CERNER
  • EPIC SYSTEMS
  • MEDITECH
  • PHILIPS HEALTHCARE
  • WOLTERS KLUWER HEALTH
  • HEARST HEALTH
  • ELSEVIER B.V.
  • IBM
  • ALLSCRIPTS HEALTHCARE SOLUTIONS

第18章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 2237

"Clinical decision support systems market is projected to grow at a CAGR of 11.8%."

The clinical decision support systems market is expected to reach USD 1,752.0 million by 2023 from USD 1,001.9 million in 2018, at a CAGR of 11.8%. Growth in the market is primarily driven by the government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of big data and mhealth tools, growing adoption of cloud computing in healthcare and partnerships between medical research groups & clinical decision support companies. However, reluctance to adopt mobile CDSS, high investments for IT infrastructure, data security concerns related to cloud-based CDSS, and lack of interoperability is likely to restrain the market to certain extent.

"Conventional CDSS to dominate the market, by application in 2017"

On the basis of application, the market has been segmented into conventional and advanced CDSS. In 2017, the conventional CDSS segment commanded the largest share of the global CDSS market. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence-based decision making, treatment planning, and protocol validation.

"Integrated CDSS segment is projected to grow at the highest CAGR during the forecast period."

Based on product, the clinical decision support systems (CDSS) market is segmented into integrated CDSS and standalone CDSS. Of these, the integrated CDSS segment accounted for the largest market share in 2017. The large share of this segment is majorly attributed to the growing deployments of integrated CDSS. Integrated CDSS are widely used by healthcare providers as they improve the quality of care and health outcomes and reduce medication errors. While using integrated solutions, users can easily switch from one type of application to another without exiting the program.

"Asia Pacific to witness the highest growth during the forecast period."

Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2017, followed by Europe, Asia Pacific, and the Rest of the World (RoW). However, Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2018-2023. Factors such as the presence of a large patient population demanding better healthcare at lower costs, economic growth, implementation of favorable government policies, increasing spending on IT infrastructure by healthcare providers, and growing focus of various market players on emerging Asian countries are driving the growth of the market in this region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
  • By Designation: Director Level: 39%, C-Level: 29%, Others: 32%
  • By Region: North America: 32%, Europe: 24%, APAC: 26%, RoW: 18%

The report includes the study of key players offering clinical decision support systems such as Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation Inc. (US), Medical Information Technology, Inc. (US), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (US), Wolters Kluwer Health (US), Hearst Health (US), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (US).

Research Coverage:

The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, level of interactivity, application, settings, and region, with analysis and forecasts to 2023. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery mode, product, type, model, user interactivity, settings, and application
  • Product Development/Innovation: Detailed insights on research and development activities and product launches in the clinical decision support systems market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the clinical decision support systems market
  • Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the clinical decision support systems market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
  • 4.2 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (2018 VS. 2023)
  • 4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY

(2018 VS. 2023) 38

  • 4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (2018 VS. 2023)
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Government support and initiatives
      • 5.2.1.2 High prevalence of chronic diseases
      • 5.2.1.3 Growing incidence of medication errors
      • 5.2.1.4 Rising prominence and usage of big data and mHealth tools
      • 5.2.1.5 High returns on investment for cdss solutions
      • 5.2.1.6 Growing adoption of cloud computing in healthcare
      • 5.2.1.7 Partnerships between medical research groups and clinical decision support companies
      • 5.2.1.8 Rapid growth in the geriatric population
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Reluctance to adopt mobile CDSS
      • 5.2.2.2 High investments for IT infrastructure
      • 5.2.2.3 Data Security concerns related to cloud-based CDSS
      • 5.2.2.4 Lack of interoperability
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Emerging markets for healthcare IT
      • 5.2.3.2 Technological advancements in healthcare IT solutions
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Integration of CDSS solutions within healthcare organizations
      • 5.2.4.2 Lack of skilled IT professionals in the healthcare industry
    • 5.2.5 US REGULATORY LANDSCAPE: CLINICAL DECISION SUPPORT SYSTEMS
      • 5.2.5.1 Clinical decision support systems and meaningful use requirements

6 CASE STUDIES

  • 6.1 INTRODUCTION
  • 6.2 DEPLOYMENT OF CDSS RESULTED IN THE EARLY DETECTION OF HIV PATIENTS
  • 6.3 IMPLEMENTATION OF CLOUD-BASED DECISION SUPPORT PLATFORM HELPED REDUCE SEPSIS MORTALITY RATE
  • 6.4 REDUCTION IN THE NUMBER OF UNNECESSARY LABORATORY TESTS AT THE INDIANA BRANCH OF THE VETERANS HEALTH ADMINISTRATION AFTER USING A CLINICAL DECISION SUPPORT TOOL
  • 6.5 USE OF CLINICAL DECISION SUPPORT TOOL HELPED REDUCE DIAGNOSTIC ERRORS

7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
  • 7.2 SERVICES
  • 7.3 SOFTWARE
  • 7.4 HARDWARE

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT

  • 8.1 INTRODUCTION
  • 8.2 INTEGRATED CDSS
  • 8.3 STANDALONE CDSS

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS
  • 9.3 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS

10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL

  • 10.1 INTRODUCTION
  • 10.2 KNOWLEDGE-BASED CDSS
  • 10.3 NON-KNOWLEDGE-BASED CDSS

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE

  • 11.1 INTRODUCTION
  • 11.2 ON-PREMISE CDSS
  • 11.3 CLOUD-BASED CDSS

12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS
  • 12.3 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS

13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY

  • 13.1 INTRODUCTION
  • 13.2 ACTIVE CDSS
  • 13.3 PASSIVE CDSS

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING

  • 14.1 INTRODUCTION
  • 14.2 INPATIENT SETTINGS
  • 14.3 AMBULATORY CARE SETTINGS

15 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 US
    • 15.2.2 CANADA
  • 15.3 EUROPE
    • 15.3.1 GERMANY
    • 15.3.2 UK
    • 15.3.3 FRANCE
    • 15.3.4 ROE
  • 15.4 ASIA PACIFIC
  • 15.5 ROW

16 COMPETITIVE LANDSCAPE

  • 16.1 OVERVIEW
  • 16.2 RANKING OF PLAYERS AND INDUSTRY CONCENTRATION, 2017
  • 16.3 COMPETITIVE SCENARIO
    • 16.3.1 PRODUCT DEPLOYMENTS, ENHANCEMENTS, AND INTEGRATIONS
    • 16.3.2 PRODUCT LAUNCHES
    • 16.3.3 AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS
    • 16.3.4 ACQUISITIONS
    • 16.3.5 EXPANSIONS

17 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 17.1 CERNER
  • 17.2 MCKESSON
  • 17.3 EPIC SYSTEMS
  • 17.4 MEDITECH
  • 17.5 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
  • 17.6 WOLTERS KLUWER HEALTH
  • 17.7 HEARST HEALTH
  • 17.8 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
  • 17.9 IBM
  • 17.10 ALLSCRIPTS HEALTHCARE SOLUTIONS

Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 18.4 AVAILABLE CUSTOMIZATIONS
  • 18.5 RELATED REPORTS
  • 18.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL POPULATION STATISTICS, 2015 VS. 2030 VS. 2050 (MILLION INDIVIDUALS)
  • TABLE 2: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 3: CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023(USD MILLION)
  • TABLE 7: INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023(USD MILLION)
  • TABLE 8: STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023(USD MILLION)
  • TABLE 9: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 13: KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 16: ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 19: CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 22: ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 25: CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2016-20213 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 30: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 37: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 38: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 39: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 40: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 41: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 42: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 43: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 45: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 46: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 48: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 50: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 51: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 52: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 53: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 55: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 56: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 57: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 59: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 60: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 61: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 62: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 63: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 64: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 65: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 67: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 68: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 69: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 70: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 71: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 72: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 73: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 75: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 USD MILLION)
  • TABLE 76: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 77: UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 78: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 79: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 80: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 81: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 82: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 83: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 84: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 85: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 86: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 87: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 88: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 89: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 91: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 92: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 93: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 94: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 95: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 96: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 97: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 99: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 100: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 101: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 102: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2016-2023 (USD MILLION)
  • TABLE 103: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • TABLE 104: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 105: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2016-2023 (USD MILLION)
  • TABLE 107: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2016-2023 (USD MILLION)
  • TABLE 108: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 109: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2016-2023 (USD MILLION)
  • TABLE 110: WOLTERS KLUWER LED THE CLINICAL DECISION SUPPORT SYSTEMS MARKET IN 2017
  • TABLE 111: PRODUCT DEPLOYMENTS (2014-2018)
  • TABLE 112: PRODUCT LAUNCHES (2014-2018)
  • TABLE 113: AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS (2014-2018)
  • TABLE 114: ACQUISITIONS (2014-2018)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL CDSS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: THE SERVICES SEGMENT DOMINATED THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, IN 2017
  • FIGURE 8: ON-PREMISE CDSS ACCOUNTED FOR THE LARGER SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, IN 2017
  • FIGURE 9: INTEGRATED CDSS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, IN 2018
  • FIGURE 10: CONVENTIONAL CDSS TO CONTINUE TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, IN 2023
  • FIGURE 11: KNOWLEDGE-BASED CDSS ACCOUNTED FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, IN 2017
  • FIGURE 12: ACTIVE CDSS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY LEVEL OF INTERACTIVITY, DURING THE FORECAST PERIOD
  • FIGURE 13: THERAPEUTIC CDSS COMMANDED THE LARGER SHARE OF THE MARKET, BY TYPE, IN 2017
  • FIGURE 14: INPATIENT SETTINGS TO DOMINATE THE CDSS MARKET, BY SETTING, DURING THE FORECAST PERIOD
  • FIGURE 15: ASIA PACIFIC TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: GOVERNMENT INITIATIVES TO DRIVE THE ADOPTION OF CDSS SOLUTIONS DURING THE FORECAST PERIOD
  • FIGURE 17: KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, IN 2018
  • FIGURE 18: ACTIVE CLINICAL DECISION SUPPORT SYSTEMS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, IN 2018
  • FIGURE 19: ADVANCED CDSS SEGMENT COMMANDS THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, IN 2018
  • FIGURE 20: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 21: CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29: INPATIENT SETTINGS ACCOUNTED FOR LARGEST SHARE OF THE CDSS MARKET
  • FIGURE 30: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2017
  • FIGURE 31: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 32: EUROPE: MARKET SNAPSHOT
  • FIGURE 33: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 34: ROW: MARKET SNAPSHOT
  • FIGURE 35: KEY DEVELOPMENTS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET BETWEEN 2014 AND 2018
  • FIGURE 36: CERNER: COMPANY SNAPSHOT
  • FIGURE 37: MCKESSON: COMPANY SNAPSHOT
  • FIGURE 38: MEDITECH: COMPANY SNAPSHOT
  • FIGURE 39: PHILIPS: COMPANY SNAPSHOT
  • FIGURE 40: WOLTERS KLUWER: COMPANY SNAPSHOT
  • FIGURE 41: RELX GROUP: COMPANY SNAPSHOT
  • FIGURE 42: IBM: COMPANY SNAPSHOT
  • FIGURE 43: ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT
Back to Top